Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MonoGerm
ISRCTN51537899Phase 2Recruiting
- Sponsor
- University of Birmingham
- Start
- Jun 2025
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules
01
Overview
Phase 2, open-label trial of carboplatin and vinblastine in brain germinoma (3 arms), sponsored by University of Birmingham. Primary endpoint: Complete Response. Started Jun 2025; status: recruiting.
02
Drugs
carboplatinvinblastine
03
Conditions
brain germinoma
Beyond the preview
Go deeper on ISRCTN51537899.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN51537899.